Literature DB >> 23966351

Lobeline Effects on Cognitive Performance in Adult ADHD.

Catherine A Martin1, Paul A Nuzzo1, John D Ranseen1, Mark S Kleven2, Greg Guenthner1, Yolanda Williams1, Sharon L Walsh1, Linda P Dwoskin1.   

Abstract

OBJECTIVE: In preclinical studies, lobeline inhibited hyperactivity induced by nicotine and amphetamine, and improved performance and learning in studies utilizing radial-arm maze and spatial-discrimination water maze. This laboratory proof-of-concept study investigated lobeline as a treatment for ADHD symptoms in adults (31.11 ± 7.08 years).
METHOD: Using cognitive tasks and self-report measures, the effects of lobeline (0, 7.5, 15, or 30 mg, s.l.) and methylphenidate (0, 15, or 30 mg, p.o.) were assessed in nine volunteers with ADHD.
RESULTS: Evidence suggested that lobeline could modestly improve working memory in adults with ADHD, but no significant improvement in attention was observed. Lobeline administration was associated with mild adverse side effects (nausea).
CONCLUSION: Further investigation of lobeline on working memory may be warranted.

Entities:  

Keywords:  ADHD; lobeline; methylphenidate

Mesh:

Substances:

Year:  2013        PMID: 23966351      PMCID: PMC4062608          DOI: 10.1177/1087054713497791

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  33 in total

Review 1.  The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics.

Authors:  Edmund J S Sonuga-Barke
Journal:  Neurosci Biobehav Rev       Date:  2003-11       Impact factor: 8.989

Review 2.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

3.  Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder.

Authors:  T Spencer; J Biederman; T Wilens; J Prince; M Hatch; J Jones; M Harding; S V Faraone; L Seidman
Journal:  Am J Psychiatry       Date:  1998-05       Impact factor: 18.112

Review 4.  A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse.

Authors:  Linda P Dwoskin; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2002-01-15       Impact factor: 5.858

5.  Cardiovascular effects of lobeline.

Authors:  A D Korczyn; I Bruderman; K Braun
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-12

6.  Neuropsychological performance in adult attention-deficit hyperactivity disorder: meta-analysis of empirical data.

Authors:  Claudia Schoechlin; Rolf R Engel
Journal:  Arch Clin Neuropsychol       Date:  2005-08       Impact factor: 2.813

7.  Lobeline augments and inhibits cocaine-induced hyperactivity in rats.

Authors:  James E Polston; Colin S Cunningham; Kelli R Rodvelt; Dennis K Miller
Journal:  Life Sci       Date:  2006-05-17       Impact factor: 5.037

8.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder.

Authors:  Adam R Aron; Jonathon H Dowson; Barbara J Sahakian; Trevor W Robbins
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

10.  Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.

Authors:  Dennis K Miller; John R Lever; Kelli R Rodvelt; James A Baskett; Matthew J Will; George R Kracke
Journal:  Drug Alcohol Depend       Date:  2007-03-21       Impact factor: 4.492

View more
  4 in total

1.  Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry.

Authors:  Hon-Cheong So; Carlos Kwan-Long Chau; Wan-To Chiu; Kin-Sang Ho; Cho-Pong Lo; Stephanie Ho-Yue Yim; Pak-Chung Sham
Journal:  Nat Neurosci       Date:  2017-08-14       Impact factor: 24.884

2.  From cis-Lobeline to trans-Lobeline: Study on the Pharmacodynamics and Isomerization Factors.

Authors:  Huan-Hua Xu; Liang Yang; Ming-Xia Tang; An-Ping Ye; Bo-Dan Tu; Zhen-Hong Jiang; Jian-Feng Yi
Journal:  Molecules       Date:  2022-09-22       Impact factor: 4.927

Review 3.  Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update.

Authors:  Parina Asgharian; Cristina Quispe; Jesús Herrera-Bravo; Mahsa Sabernavaei; Kamran Hosseini; Haleh Forouhandeh; Tahereh Ebrahimi; Paria Sharafi-Badr; Vahideh Tarhriz; Saiedeh Razi Soofiyani; Paweł Helon; Jovana Rajkovic; Sevgi Durna Daştan; Anca Oana Docea; Javad Sharifi-Rad; Daniela Calina; Wojciech Koch; William C Cho
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

Review 4.  Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders.

Authors:  Ghulam Hussain; Azhar Rasul; Haseeb Anwar; Nimra Aziz; Aroona Razzaq; Wei Wei; Muhammad Ali; Jiang Li; Xiaomeng Li
Journal:  Int J Biol Sci       Date:  2018-03-09       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.